ORIAHNN (COPACKAGED) FDA approval date
The FDA approved ORIAHNN (COPACKAGED) on 29 May 2020.
- FDA approval date
- 29 May 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as ELAGOLIX SODIUM; ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-05-29Day | ORIAHNN (COPACKAGED) | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213388", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["ORIAHNN (COPACKAGED)"], "active_ingredients": ["ELAGOLIX SODIUM", "ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200529", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |